Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07711197 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Hemoadsorption on Vascular Integrity in Septic Shock

Study acronym: ADSORP-VIP
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to investigate the effects of adjunctive CytoSorb hemoadsorption therapy versus standard medical treatment on endothelial dysfunction in patients with refractory septic shock. The investigators hypothesize that hemoadsorption mitigates endothelial and glycocalyx injury by removing inflammatory mediators and other injurious circulating molecules, promoting hemodynamic stabilization.
Trial Details
NCT Number NCT07711197
Lead Sponsor Semmelweis University
Collaborators: Ludwig Boltzmann Institute for Traumatology - The research center in cooperation with AUVA
Conditions
(from sponsor)		 Septic Shock
Related terms Sepsis, Shock, Septic, Vasoplegia
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov